Bull case
The bull case requires both strong earnings delivery and the market pricing RKLB more generously than it does today.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where RKLB stock could go
The bull case requires both strong earnings delivery and the market pricing RKLB more generously than it does today.
The base case reflects analyst consensus expectations — steady delivery without requiring a major catalyst or re-rating.
The bear case reflects a scenario where earnings shortfalls or multiple compression combine to materially reduce the stock from its current level.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Rocket Lab is a space technology company that provides small satellite launch services and manufactures spacecraft components. It generates revenue primarily through launch services—using its Electron rocket—and space systems sales including satellite platforms and components, with government contracts representing a significant portion. The company's key advantage is its proven, reliable small launch vehicle platform and vertically integrated manufacturing capabilities that allow rapid, cost-effective access to space.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q2 2025 | $-0.12/$-0.11 | -12.6% | $123M/$121M | +1.0% |
| Q3 2025 | $-0.10/$-0.10 | -5.0% | $144M/$135M | +6.7% |
| Q4 2025 | $0.01/$-0.10 | +110.1% | $155M/$152M | +2.2% |
| Q1 2026 | $-0.09/$-0.10 | +8.9% | $180M/$177M | +1.6% |
RKLB beat EPS estimates in 2 of 4 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $15 — implies -81.3% from today's price.
| Metric | RKLB | S&P 500 | Industrials | 5Y Avg RKLB |
|---|---|---|---|---|
| Forward PE | — | 19.1x | 20.7x | — |
| Trailing PE | -212.9x | 25.1x-948% | 25.7x-930% | — |
| PEG Ratio | — | 1.72x | 1.64x | — |
| EV/EBITDA | — | 15.2x | 13.7x | — |
| Price/FCF | — | 21.1x | 21.2x | — |
| Price/Sales | 75.4x | 3.1x+2310% | 1.6x+4654% | 16.1x+369% |
| Dividend Yield | — | 1.87% | 1.27% | — |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolKey financial metrics for RKLB are shown below.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
* Elevated by buyback-compressed equity — compare ROIC (-19.9%) for an undistorted picture of capital efficiency.
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Rocket Lab has posted net losses of $198.2M in 2025, $190.2M in 2024, and $182.6M in 2023. The company expects continued losses for at least the next 12 months and may never reach profitability, requiring additional equity raises that could dilute shareholders.
The company faces manufacturing delays, damage during pre‑launch, and outright launch failures that can erode revenue and reputation. Neutron rocket’s debut has been pushed from 2024 to 2026 or later, adding costs and raising doubts about meeting future contracts.
Rocket Lab competes with established players like SpaceX and Blue Origin; its Neutron rocket has lower payload capacity than SpaceX’s Falcon 9 and faces aggressive pricing competition. Loss of market share or contract acquisition could materially reduce revenue.
Inflation, rising interest rates, and potential recessions can reduce customers’ spending on launch services. Geopolitical events such as wars increase market volatility and could impact demand for space systems.
Disruptions to Rocket Lab’s computer systems, including cyber‑attacks, could impair operations, delay launches, and expose sensitive data.
Notable insider selling of shares may signal management concerns and could weigh on investor sentiment.
Failure to meet contractual requirements or comply with regulatory hurdles could delay launches, incur penalties, or force costly redesigns.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
Rocket Lab has expanded beyond launch services into satellite development, spacecraft components, and on-orbit management, capturing a broader share of the space market. Strategic acquisitions reinforce this integration, enabling higher margins and diversified income streams.
The Electron launch vehicle has maintained a flawless record, achieving 100% mission success in 2025 to date. This reliability differentiates Rocket Lab in a competitive launch market and supports repeat launch cadence.
The next‑generation Neutron rocket is a reusable, medium‑lift vehicle that can carry substantially more mass than Electron, opening a larger addressable market. Its development is expected to significantly increase Rocket Lab’s revenue potential.
Rocket Lab secured a $816 million award from the U.S. Space Development Agency for advanced satellites, underscoring its role in national security and defense. This contract adds a sizable, high‑value backlog to the company’s pipeline.
Despite current losses, Rocket Lab’s revenue is scaling rapidly, with analysts projecting a 41% compound annual growth rate over the next three years. Gross margins are improving, indicating a path toward profitability.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
RKL RKLB Rocket Lab USA, Inc. | $45.3B | — | +37.1% | -32.9% | Buy | +17.2% |
SPC SPCE Virgin Galactic Holdings, Inc. | $155M | — | +352.6% | -17615.7% | Hold | +8.2% |
MNT MNTS Momentus Inc. | $3M | — | -63.8% | -3445.3% | — | — |
AST ASTS AST SpaceMobile, Inc. | $18.7B | — | +54.1% | -482.2% | Buy | +62.3% |
BA BA The Boeing Company | $176.9B | 4835.8x | +14.0% | 2.5% | Buy | +17.5% |
LMT LMT Lockheed Martin Corporation | $117.3B | 17.0x | +5.1% | 6.4% | Buy | +24.8% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
Common questions answered from live analyst data and company financials.
Rocket Lab USA, Inc. (RKLB) is rated Buy by Wall Street analysts as of 2026. Of 18 analysts covering the stock, 13 rate it Buy or Strong Buy, 4 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $92, implying +17.2% from the current price of $79.
The Wall Street consensus price target for RKLB is $92 based on 18 analyst estimates. The high-end target is $105 (+33.3% from today), and the low-end target is $69 (-12.4%).
Forward earnings data for RKLB is not currently available. Review the valuation table above for trailing P/E, EV/EBITDA, and price-to-sales comparisons against market and sector benchmarks.
The primary risks for RKLB in 2026 are: (1) Profitability & Cash Burn — Rocket Lab has posted net losses of $198. (2) Launch Reliability & Timing — The company faces manufacturing delays, damage during pre‑launch, and outright launch failures that can erode revenue and reputation. (3) Competitive Landscape — Rocket Lab competes with established players like SpaceX and Blue Origin; its Neutron rocket has lower payload capacity than SpaceX’s Falcon 9 and faces aggressive pricing competition. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates RKLB will report consensus revenue of $825M (+37.1% year-over-year) and EPS of $-0.30 (+14.3% year-over-year) for the upcoming fiscal year. The following year, analysts project $1.1B in revenue.
Rocket Lab USA, Inc. is expected to report its next earnings on approximately 2026-05-07. Consensus expects EPS of $-0.04 and revenue of $190M. Over recent quarters, RKLB has beaten EPS estimates 42% of the time.
Rocket Lab USA, Inc. (RKLB) had a free cash outflow of $322M in free cash flow over the trailing twelve months — a free cash flow margin of 53.5%. RKLB returns capital to shareholders through and share repurchases ($0 TTM).